LY 2228820 | p38 MARK 抑制剂
LY 2228820
CAS 862505-00-8
C24H29FN6 MW 420.53
Purity: 99%
Soluble in DMSO to 92 mM
|
Biological Activity:
Potent p38 MAPK inhibitor (IC50: 7 and 3 nM for p38α and p38β MAPKs respectively); antitumor agent for the treatment of multiple myeloma (MM) patients by reducing skeletal events and enhancing cytotoxicity of bortezomib(Axon 1810).
References:
K Ishitsuka et al. p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications. Br. J. Haematol. 2008, 141(5), 598-606.
Chemical Name: 5-(2-tert-butyl-5-(4-fluorophenyl)-1H-imidazol-4-yl)-3-neopentyl-3H-imidazo[4,5-b]pyridin-2-amine
|
| LY 2228820 | p38 MAPK inhibitor | Axon Medchem | Axon 1895 | LY2228820 |
Axon Ligands TM - Research chemicals for biological study. Some high-profile samples could be provided under terms of contract research synthesis.
| 单位名称: |
|
详细地址:
北京市海淀区澄湾街19号院大北农凤凰国际创新园5号楼
|
|
qq:
2477120690
|
| 联系电话: |
| Email: |